Opharmic Technology Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Investors
-
7
Opharmic Technology General Information
Description
Manufacturer of medical devices intended to replace invasive eye injections with non-invasive ultrasound systems. The company offers a drug-agnostic delivery platform, transient permeability enhancement, ultrasound biomechanical cell stimulation, needle-free systemic delivery, and programmable cellular response, enabling pharmaceutical partners to adopt acoustic stimulation technology for molecular delivery without invasive needles.
Contact Information
Website
www.opharmic.comCorporate Office
- Unit 901 & 907, 9th Floor
- West Wing, Tsim Sha Tsui Center Salisbury Road, Tsim Sha Tsui, Kowloon
- Hong Kong
- Hong Kong
Corporate Office
- Unit 901 & 907, 9th Floor
- West Wing, Tsim Sha Tsui Center Salisbury Road, Tsim Sha Tsui, Kowloon
- Hong Kong
- Hong Kong
Opharmic Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series A) | 20-Jun-2025 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 18-May-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 30-May-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 22-Jan-2021 | Cancelled | Generating Revenue | |||
| 5. Early Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 20-Jan-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup | |||
| 1. Grant | $19.3K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Opharmic Technology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Opharmic Technology Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pebble Accelerator | Venture Capital | Minority | ||
| Shanghai Healthcare Capital | PE/Buyout | Minority | ||
| MassChallenge | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| HKSTP Ventures | Corporate Venture Capital | Minority |
Opharmic Technology FAQs
-
When was Opharmic Technology founded?
Opharmic Technology was founded in 2016.
-
Where is Opharmic Technology headquartered?
Opharmic Technology is headquartered in Hong Kong, Hong Kong.
-
What is the size of Opharmic Technology?
Opharmic Technology has 4 total employees.
-
What industry is Opharmic Technology in?
Opharmic Technology’s primary industry is Therapeutic Devices.
-
Is Opharmic Technology a private or public company?
Opharmic Technology is a Private company.
-
What is Opharmic Technology’s current revenue?
The current revenue for Opharmic Technology is .
-
Who are Opharmic Technology’s investors?
Pebble Accelerator, Shanghai Healthcare Capital, MassChallenge, MedTech Innovator, and HKSTP Ventures are 5 of 7 investors who have invested in Opharmic Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
